drugset / Trial / NCT01212367

Intrapleural Gene Transfer for Pleural Mesothelioma

NCT01212367

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This research will study how to activate the immune system by using gene transfer. Gene transfer involves inserting a specially designed gene into cancer cells. A gene is a part of the genetic code that instructs the cells of our bodies to produce specific compounds (proteins) important for the makeup or function of the cell. The study hypothesis is that repeated doses of SCH 721015 given over a three day interval would result in gene transfer.

Timeline

Start
2009-02
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Nadofaragene Firadenovec Unknown 3e+11 vg Intrathecal
Subject Nadofaragene Firadenovec Unknown 1e+12 vg Intrathecal